热门出版物 - 学术资源搜索

引用“”的文章FGFR-altered cholangiocarcinoma

标题/作者	年份
Molecular therapies and precision medicine for hepatocellular carcinoma JM Llovet, R Montal, D Sia, RS Finn Nature reviews Clinical oncology 15 (10), 599-616	2018
Cholangiocarcinoma 2020: the next horizon in mechanisms and management JM Banales, JJG Marin, A Lamarca, PM Rodrigues, SA Khan, LR Roberts, ... Nature reviews Gastroenterology & hepatology 17 (9), 557-588	2020
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study GK Abou-Alfa, V Sahai, A Hollebecque, G Vaccaro, D Melisi, R Al-Rajabi, ... The Lancet Oncology 21 (5), 671-684	2020
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study GK Abou-Alfa, T Macarulla, MM Javle, RK Kelley, SJ Lubner, J Adeva, ... The Lancet Oncology 21 (6), 796-807	2020
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial A Lamarca, DH Palmer, HS Wasan, PJ Ross, YT Ma, A Arora, S Falk, ... The Lancet Oncology 22 (5), 690-701	2021
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma V Mazzaferro, BF El-Rayes, M Droz dit Busset, C Cotsoglou, WP Harris, ... British journal of cancer 120 (2), 165-171	2019
Biliary tract cancer JW Valle, RK Kelley, B Nervi, DY Oh, AX Zhu The Lancet 397 (10272), 428-444	2021
Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): A phase 2, open-label, single-arm, multicentre basket trial V Subbiah, U Lassen, E Élez, A Italiano, G Curigliano, M Javle, ... The Lancet Oncology 21 (9), 1234-1243	2020
Advances in bladder cancer biology and therapy L Tran, JF Xiao, N Agarwal, JE Duex, D Theodorescu Nature Reviews Cancer 21 (2), 104-121	2021
TAS-120 overcomes resistance to ATP-competitive FGFR inhibitors in patients with FGFR2 fusion–positive intrahepatic cholangiocarcinoma L Goyal, L Shi, LY Liu, F Fece de la Cruz, JK Lennerz, S Raghavan, ... Cancer discovery 9 (8), 1064-1079	2019
From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer C Nevala-Plagemann, M Hidalgo, I Garrido-Laguna Nature reviews Clinical oncology 17 (2), 108-123	2020
Fibroblast growth factor receptors as treatment targets in clinical oncology M Katoh Nature reviews Clinical oncology 16 (2), 105-122	2019
Molecular targeted therapies: ready for “prime time” in biliary tract cancer A Lamarca, J Barriuso, MG McNamara, JW Valle Journal of hepatology 73 (1), 170-185	2020
Real-time targeted genome profile analysis of pancreatic ductal adenocarcinomas identifies genetic alterations that might be targeted with existing drugs or used as biomarkers AD Singhi, B George, JR Greenbowe, J Chung, J Suh, A Maitra, ... Gastroenterology 156 (8), 2242-2253. e4	2019
Systemic therapies for intrahepatic cholangiocarcinoma RK Kelley, J Bridgewater, GJ Gores, AX Zhu Journal of hepatology 72 (2), 353-363	2020
Intrahepatic cholangiocarcinoma: continuing challenges and translational advances AE Sirica, GJ Gores, JD Groopman, FM Selaru, M Strazzabosco, ... Hepatology 69 (4), 1803-1815	2019
Cholangiocarcinoma PJ Brindley, M Bachini, SI Ilyas, SA Khan, A Loukas, AE Sirica, BT Teh, ... Nature reviews Disease primers 7 (1), 65	2021
Liver resection and transplantation for intrahepatic cholangiocarcinoma V Mazzaferro, A Gorgen, S Roayaie, MD dit Busset, G Sapisochin Journal of hepatology 72 (2), 364-377	2020
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study M Javle, S Roychowdhury, RK Kelley, S Sadeghi, T Macarulla, KH Weiss, ... The Lancet Gastroenterology & Hepatology 6 (10), 803-815	2021
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma R Montal, D Sia, C Montironi, WQ Leow, R Esteban-Fabró, R Pinyol, ... Journal of hepatology 73 (2), 315-327	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。